Impact of Male Hormonal Contraception on Prostate Androgens and Androgen Action in Healthy Men: A Randomized, Controlled Trial | Zendy

Elahe A. Mostaghel | Zendy; Daniel W. Lin | Zendy; John K. Amory | Zendy; Jonathan L. Wright | Zendy; Brett T. Marck | Zendy; Peter S. Nelson | Zendy; Alvin M. Matsumoto | Zendy; William J. Bremner | Zendy; Stephanie T. Page | Zendy

Open Access

Impact of Male Hormonal Contraception on Prostate Androgens and Androgen Action in Healthy Men: A Randomized, Controlled Trial

Author(s) -

Elahe A. Mostaghel,

Daniel W. Lin,

John K. Amory,

Jonathan L. Wright,

Brett T. Marck,

Peter S. Nelson,

Alvin M. Matsumoto,

William J. Bremner,

Stephanie T. Page

Publication year - 2012

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2012-1536

Subject(s) - dihydrotestosterone , testosterone (patch) , medicine , androgen , endocrinology , prostate , placebo , dutasteride , androgen receptor , antiandrogen , prostate cancer , urology , hormone , cancer , alternative medicine , pathology

Male hormonal contraception (MHC) combines hypothalamic-pituitary-gonadal axis blockade with exogenous androgen delivery to maintain extragonadal androgen end-organ effects. Concern exists that MHC may adversely impact prostate health.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research